Acquisitions, Mergers & PartnershipsBioprintingMoney & Funding

Aspect Biosystems Closes First Institutionally Led Round of Financing

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Aspect Biosystems Ltd., a privately held biotechnology company commercializing cutting-edge bioprinting technologies, has completed its first institutionally led round of financing.

The private financing round was led by Pangaea Ventures and included investments by Endure Capital, Pallasite Ventures, Relentless Pursuit Partners, and other new and existing investors. Aspect will use proceeds from this financing to fund ongoing technology and product development, expand its strategic partnerships, and ultimately accelerate the commercialization of its Lab-on-a-Printer™ bioprinting platform and tissue applications.

“We believe 3D bioprinting technology has tremendous potential to improve the way we develop therapeutics and treat disease and are excited to bring on a group of quality investors who believe in our bold vision,” said Tamer Mohamed, President and CEO of Aspect Biosystems. “With the financial and strategic support of our investors and partners, we will continue to use our Lab-on-a-Printer™ bioprinting technology to enable critical advancements in biological research, therapeutic development, and clinical practice.”

Aspect Biosystems is operating at the leading edge of 3D bioprinting and tissue engineering. The company’s proprietary Lab-on-a-Printer™ platform technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to create physiologically and commercially relevant tissues. These tissues are used to advance and accelerate the discovery and development of new drugs and therapies.

“Pangaea has been following the progress of Aspect for the last several years and has witnessed the tremendous progress over that time,” said Andrew Haughian, Partner at Pangaea Ventures. “We truly believe Aspect has developed the world’s leading bioprinting platform and we’re absolutely thrilled to partner with the team as the company enters an exciting period of growth.”

Pangaea is the world leader in advanced materials venture capital. It invests in companies using advanced material technologies that make our world better. Established in 2000, Pangaea has built an outstanding portfolio addressing multi-billion dollar markets in energy, electronics, health, and sustainability. Its unmatched materials network spans multiple industry verticals and includes world-leading Strategic Limited Partners across North America, Asia, Europe and the Middle East.

Research
Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

VoxelMatters

VoxelMatters is the online trade media portal published by 3dpbm, a leading marketing and market research firm specializing in the AM industry. 3dpbm also publishes the 3D Printing Business Directory, the AM Focus eBook series and the 3dpbm Research AM Market Reports. 3D Printing Media Network was founded with the goal to provide the latest industry news, insights and opinions to a global audience of professionals and decision makers.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services

Newsletter

Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.